Document is current
Any future updates will be listed below
-
Authors
Sohai, Danielle K. https://orcid.org/0000-0003-0186-2975
Keller, Michael D. https://orcid.org/0000-0001-8323-3085
Hanley, Patrick J. https://orcid.org/0000-0002-0102-7892
Hoq, Fahmida
Kukadiya, Divyesh
Datar, Anushree
Reynolds, Emily
Copertino, Dennis C. https://orcid.org/0000-0002-3217-4713
Lazarski, Christopher https://orcid.org/0000-0001-8917-7280
McCann, Chase D.
Tanna, Jay
Shibli, Abeer
Lang, Haili
Zhang, Anqing
Chansky, Pamela A. https://orcid.org/0000-0002-8169-992X
Motta, Cecilia
Huynh, Tan T. https://orcid.org/0009-0009-0286-3946
Dwyer, Bridget
Wilson, Andrew
Lynch, Rebecca
Mota, Talia M.
Conce Alberto, Winiffer D.
Brumme, Zabrina L. https://orcid.org/0000-0002-8157-1037
Kinloch, Natalie N.
Cruz, Conrad Russell Y. https://orcid.org/0000-0001-7065-3769
MacLaren Ehui, Lynsay
Henn, Sarah
Brad Jones, R. https://orcid.org/0000-0003-4470-1231
Bollard, Catherine M. https://orcid.org/0000-0001-5140-9090
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (5UM1AI126617-04)
American Society of Hematology
Michael Smith Foundation for Health Research
Gouvernement du Canada | Canadian Institutes of Health Research
- License Information
-
More Information
Article History
Received: 4 June 2024
Accepted: 6 May 2025
First Online: 15 May 2025
Competing interests
: C.M.B. is on the Board of Directors of Cabaletta Bio and was the scientific co-founder and scientific advisory board member of Catamaran Bio, has stock in Repertoire Immune Medicines and serves on the data and safety monitoring board (DSMB) of the Swedish Orphan Biovitrum (SOBI). PJH is an advisor or member of on an advisory board of Autolomous, CARTx, Celleknos, Cipla, March Biosciences, MFX, and Y Innovations. M.D.K. is an author for Elsevier (Uptodate) and has received research funding from Chiesi Pharmaceuticals. All other authors declare no competing interests.
